Learn More

BioPharmaceutical Emerging Best Practices Association (BEBPA)

We aim to foster publication of white papers clarifying problems faced by biopharmaceutical community – companies, regulators, clinicians - during product development and identifying emerging issues which could benefit from early discussion.

Learn More
Welcome to the BioPharmaceutical Emerging Best Practices Association (BEBPA) , a non-profit organization managed by and for the benefit of the biopharmaceutical scientific community.  BEBPA provides an international forum for the presentation and discussion of scientific issues and problems encountered in the biopharmaceutical community.  The aim of this open discussion is to promote development of innovative approaches and solutions thus facilitating safer and faster biopharmaceutical product development.

One of BEBPA’s aims is to foster publication of white papers clarifying problems faced by biopharmaceutical community – companies, regulators, clinicians - during product development and identifying emerging issues which could benefit from early discussion.  Smaller conferences will then be held on these topics and a non-consensus white paper will be published delineating various approaches to solving these problems.  The papers are not intended to be guidance documents, but rather will strive to present the scientific community with a variety of approaches to potentially solve a common problem.  Since the papers are not consensus documents, nor prescribe a preferred approach, publication will occur rapidly and thus be part of the scientific discussion.  Additionally it is hoped that the  publication of potential problem-solving approaches the biopharmaceutical scientific community will accelerate the rate at which a future consensus best practice can be established.

Helpful Information

Download the PDF
2014 BEBPA Bioassay Brochure

 

2014 Bioassay Conference
Want to sign up for the Bioassay Conference? If so, then fill out the secure form and we will confirm your order via email shortly after. Click Here

"The comments regarding statistical analysis are very relevant to my daily work."
Sefan C., Statens Serum Institute
"Thank you for giving a niche training with affordable price."
Ammir S., Hikma, Pharmaceuticals Jordan
"Technically rejuvenating."
Nabeel H., Gulf Pharmaceutical Industries
"It was a wonderful collaborative and productive experience."
Patrick N., Janssen R&D LLC
"Lively and relevant discussions."
Harold T., Merz Pharmaceuticals
"A conference with perfect atmosphere for discussions!"
Mette O., Novo Nordisk A/S
"Interesting talks, great atmosphere, good discussion, nice people joining the conference."
Sonja K., Richter-Helm-Biologics
"It allows you to see what others in your field are doing. Without this meeting, it would be impossible for some of us to get this information."
Sheri K., Ligocyte Pharmaceuticals